AzTrials
AzTrials

Research institution

Peking Union Medical College Hospital Clinical Trials

Studies where Peking Union Medical College Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

1,154 registered studies

In numbers

Open to volunteers
303
Active
332
With results posted
8
All registered
1,154

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 303
  • Cervical Cancer Screening

    Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer

    • Enrolling by invitation
    • Age: 18 to 70 years
    • Observational study

    This is a prospective, single-center, observational cohort study that plans to enroll 100 women aged 18 years or older with histologically confirmed cervical cancer who are scheduled to receive radical surgery, radiotherapy, or…

    Trial name
    NCT07919431
    Testing
    Low-depth cfDNA fragmentomics testing
    Where
    China
    Volunteers
    100 people
    Sponsor
    Peking Union Medical College Hospital
  • Colorectal Cancer

    A Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and Immune Evasion

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Surgery or procedure

    Colorectal cancer (CRC) has shifted toward a patient-personalized precision medicine paradigm; however, the high heterogeneity and complex tumor microenvironment (TME) of CRC restrict the development of individualized therapy…

    Trial name
    NCT07919418
    Testing
    Surgical resection and adjuvant chemotherapy
    Where
    China
    Volunteers
    60 people
    Sponsor
    Peking Union Medical College Hospital
  • Atrial Fibrillation, Atrial Fibrillation Recurrent

    Atrial Fibrillation Patients Treated With Catheter Ablation

    • Recruiting
    • Age: 18 to 80 years
    • Observational study
    • Surgery or procedure

    This is a single-center prospective observational cohort study of atrial fibrillation patients treated with radiofrequency ablation.

    Trial name
    NCT05266144
    Testing
    radiofrequency ablation
    Where
    China
    Volunteers
    300 people
    Sponsor
    Peking Union Medical College Hospital
  • Gestational Trophoblastic Neoplasia

    Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

    • Recruiting
    • Age: 18 to 60 years
    • Phase 2

    The purpose of this study is to evaluate the efficacy and safety of camrelizumab and apatinib as combination therapy in patients with ultra high-risk (Cohort A) and high-risk chemo-refractory or relapsed (Cohort B) gestational…

    Trial name
    NCT05139095
    Testing
    Camrelizumab plus apatinib CohortA, Camrelizumab plus apatinib Cohort B
    Where
    China
    Volunteers
    70 people
    Sponsor
    Peking Union Medical College Hospital
  • Cervical Cancer, Adaptive Radiotherapy

    Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

    • Recruiting
    • Age: 18 to 75 years
    • Phase 3

    The most common external beam radiotherapy fractionation scheme for cervical cancer is 45-50.4 Gy delivered in 25-28 fractions. However, prolonged treatment duration can lead to insufficient availability of medical resources.

    Trial name
    NCT06641635
    Testing
    Moderated hypofractionated online adaptive radiotherapy, Conventional radiotherapy
    Where
    China
    Volunteers
    440 people
    Sponsor
    Peking Union Medical College Hospital
  • Cushing s Syndrome

    Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

    • Recruiting
    • Age: 10 to 80 years
    • Phase 1/2

    In previous clinical practice, 68Ga-Pentixafor PET/CT has demonstrated promising diagnostic utility in various neuroendocrine tumors by targeting CXCR4, a chemokine receptor overexpressed in several ACTH-secreting neoplasms.

    Trial name
    NCT07350707
    Testing
    68Ga-Pentixafor
    Where
    China
    Volunteers
    160 people
    Sponsor
    Peking Union Medical College Hospital
  • Glycogen Storage Disease

    Neurocognitive Function and Neuroimaging Features in Patients With Glycogen Storage Diseases

    • Recruiting
    • Age: 3 to 40 years
    • Observational study

    The goal of this observational study is to learn about cognitive function and brain imaging findings in people with glycogen storage disease (GSD).

    Trial name
    NEURO-GSD (NCT07908212)
    Where
    China
    Volunteers
    318 people, healthy volunteers welcome
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NEURO-GSD
  • Cervical Neuroendocrine Carcinoma

    Immunotherapy in Neuroendocrine Carcinoma of the Cervix

    • Not yet recruiting
    • Age: 18 to 100 years
    • Observational study

    This retrospective study reviews existing medical records. No new treatments or tests are given. The study asks how well immunotherapy worked for people with a rare cancer called neuroendocrine carcinoma of the cervix.

    Trial name
    NCT07911423
    Testing
    No study intervention; observational study.
    Where
    China
    Volunteers
    150 people
    Sponsor
    Peking Union Medical College Hospital
  • Cerebral Small Vessel Disease, Ischemic Stroke

    Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease

    • Recruiting
    • Age: 30 to 80 years
    • Phase 3
    • Pill or oral medicine

    This study is a multicenter, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of Edaravone Dexborneol Sublingual Tablets in patients with acute ischemic stroke due to small vessel…

    Trial name
    TASTE-SVD (NCT06674460)
    Testing
    Edaravone Dexborneol Sublingual Tablets
    Where
    China
    Volunteers
    600 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? TASTE-SVD
  • Gastrointestinal Neuroendocrine Carcinoma, Adjuvant Treatment

    Oxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma**

    • Enrolling by invitation
    • Age: 18 to 75 years
    • Observational study

    Patients with pathologically-confirmed gastrointestinal neuroendocrine carcinoma will be enrolled, to explore the efficacy and safety of oxaliplatin-based doublet chemotherapy in the adjuvant treatment of gastrointestinal…

    Conditions
    Gastrointestinal Neuroendocrine Carcinoma, Adjuvant Treatment, Resection
    Trial name
    NCT07891572
    Where
    China
    Volunteers
    42 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07891572

Completed, with results posted

All 7

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in